Article ; Online: Cerebrovascular Accident and SARS-CoV-19 (COVID-19): A Systematic Review.
2021 Volume 84, Issue 6, Page(s) 418–425
Abstract: ... of patients classified with mild or critical COVID-19 infection.: Discussion: The data suggest SARS-CoV-2 ... suggests an increased risk of cerebrovascular accident (CVA) in the setting of COVID-19 infection ... Methods: We searched 3 databases (PubMed, MEDLINE, and CINAHL) with search terms COVID-19, novel ...
Abstract | Background: While the most common neurologic symptoms reported in patients affected by SARS-CoV-2 are headache, dizziness, myalgia, mental fog, and anosmia, there is a growing basis of published peer-reviewed cases reporting stroke in the setting of SARS-CoV-2 infection. The peer-reviewed literature suggests an increased risk of cerebrovascular accident (CVA) in the setting of COVID-19 infection. Methods: We searched 3 databases (PubMed, MEDLINE, and CINAHL) with search terms COVID-19, novel coronavirus, stroke, and cerebrovascular accident. Case series and case studies presenting patients positive for both COVID-19 and CVA published from January 1 through September 1, 2020, were included. Data collection and analysis was completed and risk of bias assessed. Results: The search identified 28 studies across 7 counties comprising 73 patients. Amongst patients hospitalized for COVID-19 infection and CVA, the average age was 60; the most common preexisting conditions were hypertension and diabetes mellitus, and those without preexisting conditions were significantly younger with an average age of 47. Amongst hospitalized patients with COVID-19 and CVA, there was a bimodal association with COVID-19 infection severity with majority of patients classified with mild or critical COVID-19 infection. Discussion: The data suggest SARS-CoV-2 is a risk factor for developing stroke, particularly in patients with hypertension and diabetes. Furthermore, the younger average age of stroke in patients with SARS-CoV-2, particularly those patients with zero identifiable preexisting conditions, creates high suspicion that SARS-CoV-2 is an independent risk factor for development of stroke; however, this cannot yet be proven without comparable control population. The data suggest the risk of developing CVA in the setting of COVID-19 infection is not dependent upon severity of illness. Continued studies must be done to understand the epidemiologic factors of COVID-19 infection and stroke and the pathophysiology of the COVID-associated hypercoagulable state. |
|||||
---|---|---|---|---|---|---|
MeSH term(s) | COVID-19 ; Headache ; Humans ; Middle Aged ; SARS-CoV-2 ; Stroke/complications ; Stroke/epidemiology | |||||
Language | English | |||||
Publishing date | 2021-08-05 | |||||
Publishing country | Switzerland | |||||
Document type | Research Support, Non-U.S. Gov't ; Systematic Review | |||||
ZDB-ID | 209426-5 | |||||
ISSN | 1421-9913 ; 0014-3022 | |||||
ISSN (online) | 1421-9913 | |||||
ISSN | 0014-3022 | |||||
DOI | 10.1159/000517403 | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 575: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.